Oncogene_NN
amplification_NN
correlates_VBZ
with_IN
dense_JJ
lymphocyte_NN
infiltration_NN
in_IN
human_JJ
breast_NN
cancers_NNS
:_:
a_DT
role_NN
for_IN
hematopoietic_JJ
growth_NN
factor_NN
release_NN
by_IN
tumor_NN
cells_NNS
?_.

One_CD
hundred_CD
six_CD
primary_JJ
breast_NN
cancer_NN
samples_NNS
were_VBD
analyzed_VBN
for_IN
c-erbB2_NN
,_,
int-2_NN
,_,
and_CC
c-myc_NN
gene_NN
amplification_NN
._.

Surgically_RB
confirmed_VBN
nodal_JJ
involvement_NN
was_VBD
observed_VBN
in_IN
42_CD
%_NN
._.

Level_NN
of_IN
gene_NN
amplification_NN
was_VBD
studied_VBN
by_IN
Southern_NN
and\/or_CC
slot_JJ
blot_NN
techniques_NNS
._.

Amplified_JJ
c-erbB2_NN
gene_NN
sequences_NNS
were_VBD
present_JJ
in_IN
21.5_CD
%_NN
of_IN
all_DT
samples_NNS
._.

Int-2_NN
was_VBD
amplified_VBN
in_IN
13.1_CD
%_NN
and_CC
c-myc_NN
was_VBD
amplified_VBN
in_IN
10.3_CD
%_NN
._.

In_IN
a_DT
non-parametric_JJ
test_NN
-LRB-_-LRB-
Kruskal-Wallis_NN
-RRB-_-RRB-
a_DT
strong_JJ
negative_JJ
association_NN
was_VBD
found_VBN
between_IN
high_JJ
levels_NNS
of_IN
c-erbB2_NN
amplification_NN
and_CC
absence_NN
of_IN
estrogen_NN
receptor_NN
-LRB-_-LRB-
ER_NN
-RRB-_-RRB-
-LRB-_-LRB-
P_NN
=_JJ
.0009_CD
-RRB-_-RRB-
or_CC
progesterone_NN
receptor_NN
-LRB-_-LRB-
PR_NN
-RRB-_-RRB-
-LRB-_-LRB-
P_NN
=_JJ
.011_CD
-RRB-_-RRB-
expression_NN
._.

No_DT
correlations_NNS
were_VBD
found_VBN
between_IN
all_DT
or_CC
high_JJ
levels_NNS
of_IN
amplification_NN
of_IN
each_DT
oncogene_NN
separately_RB
or_CC
combined_VBN
with_IN
T_NN
,_,
N_NN
,_,
grade_NN
,_,
multifocality_NN
of_IN
tumor_NN
,_,
or_CC
associated_JJ
carcinoma_NN
in_FW
situ_FW
._.

There_EX
was_VBD
a_DT
trend_NN
approaching_VBG
statistical_JJ
significance_NN
for_IN
patients_NNS
with_IN
c-erbB2_NN
amplifications_NNS
to_TO
have_VB
positive_JJ
lymph_NN
nodes_NNS
at_IN
surgery_NN
-LRB-_-LRB-
P_NN
=_JJ
0.09_CD
-RRB-_-RRB-
._.

A_DT
somewhat_RB
surprising_JJ
finding_NN
however_RB
was_VBD
a_DT
very_RB
strong_JJ
association_NN
between_IN
oncogene_NN
amplification_NN
and_CC
dense_JJ
lymphocyte_NN
infiltration_NN
of_IN
the_DT
tumor_NN
-LRB-_-LRB-
P_NN
=_JJ
.05_CD
-RRB-_-RRB-
._.

This_DT
correlation_NN
is_VBZ
even_RB
stronger_JJR
when_WRB
only_RB
high_JJ
levels_NNS
of_IN
amplification_NN
are_VBP
considered_VBN
,_,
either_CC
for_IN
each_DT
oncogene_NN
separately_RB
-LRB-_-LRB-
P_NN
=_JJ
.0048_CD
-RRB-_-RRB-
or_CC
in_IN
combination_NN
-LRB-_-LRB-
P_NN
=_JJ
.0007_CD
-RRB-_-RRB-
._.

We_PRP
propose_VBP
that_IN
malignant_JJ
cell_NN
cytokine_NN
production_NN
may_MD
help_VB
explain_VB
this_DT
observation_NN
._.

